DexCom, Inc. (DXCM) NASDAQ
61.35
+1.8(+3.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
61.35
+1.8(+3.02%)
Currency In USD
| Market Cap | 25.9B |
| Enterprise Value | 26.37B |
| P/E Ratio | 25.39 |
| PEG Ratio | 0.34 |
| Price/Sales Ratio | 4.91 |
| Price/Book Ratio | 7.99 |
| Enterprise/Revenue | 4.97 |
| Enterprise/EBITDA | 18.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.19 |
| Operating Margin | 0.21 |
| Return On Assets | 0.14 |
| Return On Equity | 0.34 |
| Revenue | 4.66B |
| Revenue/Share | 12.51 |
| Gross Profit | 2.8B |
| EBITDA | 1.16B |
| Net Income | 836.3M |
| Diluted EPS | 2.09 |
| Total Cash | 2.42B |
| Total Cash/Share | 6.27 |
| Total Debt | 1.38B |
| Total Debt/Equity | 0.47 |
| Current Ratio | 1.95 |
| Book Value Per Share | 7.68 |
| 52-Week Change | -23.57 |
| 52-Week High | 89.98 |
| 52-Week Low | 54.11 |
| Moving Average 50 Days | 65.85 |
| Moving Average 200 Days | 69.49 |
| Average Volume | 4.59M |
| Shares Outstanding | 385.87M |
| % Held by Institutions | 94.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | June 13, 2022 |